Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 6 months of age.
- People whose cancer cells have been confirmed, through laboratory testing, to carry a specific protein called CD7 (or similar surface proteins) on their surface.
- People who are in generally good physical health, as measured by a standard health scoring system (called the Karnofsky scale), with a score above 80, and who have a life expectancy of more than 3 months.
- People whose heart, liver, kidneys, and bone marrow are functioning well enough to meet specific laboratory test thresholds set by the trial (confirm exact values with trial site).
- People whose blood haemoglobin level is at or above a minimum level set by the trial (confirm with trial site).
- People for whom there are no medical reasons preventing a cell collection procedure.
- People who are willing and able to understand the trial and provide written consent to participate.
Who may not be able to join:
- People with a serious illness or medical condition — including an active, uncontrolled infection — that would make it unsafe to follow the trial's treatment plan.
- People with an active bacterial, fungal, or viral infection that is not being adequately controlled by treatment.
- People with a known HIV or Hepatitis C infection.
- People who are pregnant or currently breastfeeding.
- People who have used steroid medicines (glucocorticoids) for a whole-body (systemic) treatment within one week before entering the trial.
- People who have previously received any gene therapy treatment.
- People who, in the opinion of the trial investigators, may have difficulty following the trial's requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 0755-86573763
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of infusion
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.